Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 10 | 2018 | 385 | 2.080 |
Why?
|
| Herniorrhaphy | 4 | 2016 | 16 | 1.700 |
Why?
|
| Laparoscopy | 7 | 2016 | 95 | 1.370 |
Why?
|
| Hernia, Inguinal | 3 | 2016 | 15 | 1.010 |
Why?
|
| Quality Improvement | 2 | 2014 | 78 | 0.800 |
Why?
|
| Surgical Mesh | 2 | 2013 | 15 | 0.780 |
Why?
|
| Treatment Outcome | 10 | 2016 | 1478 | 0.600 |
Why?
|
| Male | 17 | 2018 | 6815 | 0.580 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2018 | 5 | 0.580 |
Why?
|
| Middle Aged | 14 | 2018 | 4043 | 0.570 |
Why?
|
| Colectomy | 2 | 2015 | 10 | 0.550 |
Why?
|
| Female | 16 | 2018 | 6974 | 0.520 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 6 | 0.510 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 11 | 0.470 |
Why?
|
| Adult | 11 | 2018 | 3557 | 0.470 |
Why?
|
| Barrett Esophagus | 1 | 2015 | 10 | 0.460 |
Why?
|
| Smoking | 1 | 2016 | 84 | 0.460 |
Why?
|
| Gastrectomy | 1 | 2015 | 16 | 0.460 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 6 | 0.450 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 24 | 0.450 |
Why?
|
| General Surgery | 1 | 2015 | 18 | 0.450 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 4 | 0.440 |
Why?
|
| Aged | 11 | 2018 | 4000 | 0.440 |
Why?
|
| Appendectomy | 1 | 2014 | 8 | 0.440 |
Why?
|
| Appendicitis | 1 | 2014 | 11 | 0.430 |
Why?
|
| Humans | 17 | 2018 | 12240 | 0.430 |
Why?
|
| Colon, Sigmoid | 1 | 2014 | 10 | 0.420 |
Why?
|
| Scrotum | 1 | 2014 | 11 | 0.420 |
Why?
|
| Intestine, Small | 1 | 2014 | 19 | 0.410 |
Why?
|
| Sepsis | 1 | 2014 | 38 | 0.400 |
Why?
|
| Abdominal Wall | 1 | 2013 | 5 | 0.380 |
Why?
|
| Hernia, Ventral | 1 | 2013 | 8 | 0.380 |
Why?
|
| Survival Rate | 4 | 2015 | 152 | 0.340 |
Why?
|
| Retrospective Studies | 8 | 2018 | 1467 | 0.320 |
Why?
|
| Databases, Factual | 3 | 2016 | 156 | 0.320 |
Why?
|
| Risk Factors | 5 | 2016 | 1049 | 0.310 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 726 | 0.310 |
Why?
|
| Operative Time | 4 | 2018 | 38 | 0.260 |
Why?
|
| Logistic Models | 2 | 2016 | 196 | 0.230 |
Why?
|
| Heart Transplantation | 2 | 2015 | 14 | 0.210 |
Why?
|
| Graft Rejection | 2 | 2015 | 30 | 0.210 |
Why?
|
| Colonic Neoplasms | 2 | 2015 | 28 | 0.210 |
Why?
|
| Gastroplasty | 2 | 2014 | 15 | 0.200 |
Why?
|
| Obesity, Morbid | 2 | 2014 | 52 | 0.190 |
Why?
|
| Reoperation | 2 | 2016 | 366 | 0.190 |
Why?
|
| United States | 2 | 2016 | 989 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 218 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 2152 | 0.160 |
Why?
|
| Time Factors | 3 | 2015 | 695 | 0.140 |
Why?
|
| Cholecystectomy | 1 | 2018 | 3 | 0.140 |
Why?
|
| Cholecystitis, Acute | 1 | 2018 | 2 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 350 | 0.130 |
Why?
|
| Length of Stay | 2 | 2018 | 126 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 423 | 0.120 |
Why?
|
| Pneumonia | 1 | 2016 | 33 | 0.120 |
Why?
|
| Sex Factors | 1 | 2016 | 229 | 0.110 |
Why?
|
| Hernia, Umbilical | 1 | 2015 | 3 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2015 | 99 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2015 | 42 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 142 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2015 | 24 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2015 | 115 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2015 | 18 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 15 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 33 | 0.110 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 11 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 63 | 0.110 |
Why?
|
| Lymphoma | 1 | 2014 | 16 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 97 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2015 | 29 | 0.110 |
Why?
|
| Myocardium | 1 | 2015 | 81 | 0.110 |
Why?
|
| Illinois | 1 | 2014 | 110 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2015 | 72 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 168 | 0.110 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 3 | 0.100 |
Why?
|
| Graft Survival | 1 | 2014 | 44 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2015 | 295 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2014 | 22 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2014 | 31 | 0.100 |
Why?
|
| Tissue Donors | 1 | 2014 | 42 | 0.100 |
Why?
|
| Fundoplication | 1 | 2013 | 12 | 0.100 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 17 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 38 | 0.100 |
Why?
|
| Radiography | 1 | 2014 | 258 | 0.100 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 3 | 0.100 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2013 | 7 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 23 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 118 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 47 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 126 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 209 | 0.090 |
Why?
|
| Actinomycetales | 1 | 2004 | 1 | 0.050 |
Why?
|
| Erythromycin | 1 | 2004 | 1 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2004 | 4 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 863 | 0.050 |
Why?
|
| Patient Admission | 1 | 2018 | 8 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 23 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 169 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2018 | 119 | 0.030 |
Why?
|
| Los Angeles | 1 | 2015 | 1 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 33 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 66 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 85 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 61 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 36 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 55 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 151 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 214 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 125 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 34 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 363 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 78 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 827 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 1 | 0.010 |
Why?
|
| Glucosyltransferases | 1 | 2004 | 1 | 0.010 |
Why?
|
| Saccharopolyspora | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2004 | 1 | 0.010 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2004 | 1 | 0.010 |
Why?
|
| Fatty Acid Synthases | 1 | 2004 | 1 | 0.010 |
Why?
|
| Thiolester Hydrolases | 1 | 2004 | 3 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 5 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2004 | 5 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 17 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 15 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 22 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 26 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 33 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 100 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 48 | 0.010 |
Why?
|